NMN in Germany and the EU

Legal status under EU Novel Food rules: what is sold, what isn't, and what it means for consumers

Reviewed by Maurice Lichtenberg, Founder, Longevity Cities · Last updated

Updated · 8 min read

This content is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making changes to your diet, exercise routine, or supplement regimen.

What is NMN?

Nicotinamide mononucleotide (NMN) is a small molecule your body uses to build NAD+ (nicotinamide adenine dinucleotide, the coenzyme every cell needs to run its metabolism). NAD+ levels drop with age, and that single fact has powered a billion-dollar supplement story for the better part of a decade.

The pitch is straightforward: top up NAD+ from the outside, and you slow down some parts of aging. Harvard's David Sinclair is the loudest voice behind it. Yoshino 2021 showed that 250 mg of NMN improved muscle insulin sensitivity in prediabetic women, which is a real result in a small trial that has been repeated only a handful of times since.

For the science side of NMN, see our longevity supplements guide. This guide is only about the legal picture in Germany and the EU. Not dosing. Not where to buy. Not medical use. The goal here is to help you read a confusing rulebook before you spend money on something that may or may not be legal where you live.

Is NMN legal in the EU? (status May 2026)

Short answer: not yet, but it is about to change for one specific product.

The EU Novel Food regulation (Regulation (EU) 2015/2283) decides which ingredients can be sold as food or supplements anywhere in the EU. An ingredient counts as "novel" if Europeans did not eat it in any meaningful amount before 15 May 1997, and anything novel needs authorisation before it can legally go on shelves.

Where NMN actually stands:

  • The EU novel food catalogue lists NMN as a novel food that requires authorisation before it can be sold legally as a supplement anywhere in the bloc.
  • On 13 May 2026, EFSA published a positive safety opinion on EffePharm's Uthever® NMN, concluding that 300 mg per day is safe for the general adult population, excluding pregnant and breastfeeding women.
  • The European Commission and the Member States still have to adopt the actual authorisation, and that step usually follows 5 to 7 months after a positive EFSA opinion. When it lands, the authorisation will be product-specific to EffePharm and Uthever®, which means generic NMN from other producers stays under Novel Food restrictions until each applicant earns its own positive opinion and EC authorisation.

Other countries:

  • USA: The FDA pulled NMN from the dietary supplement category in late 2022 because of a parallel pharmaceutical filing for the same molecule. After citizen petitions from the Natural Products Association and the Alliance for Natural Health, the FDA issued a response letter on 29 September 2025 that set aside its 2022 superseding letter and put NMN back inside the dietary supplement definition. Regulatory reversal, not a court ruling.
  • Japan and parts of Asia: NMN is widely available and openly sold.
  • Switzerland: Outside the EU, so its own rules apply.

What this means at the till. Products marketed in Germany as "NMN supplements" sit in a legal grey zone, and selling them without novel food authorisation is technically out of compliance with EU food law. The common workaround is to label the product as "laboratory chemical" or "for research use only," which is not the same as being officially cleared for human consumption.

The DACH supplement market in practice. German brands such as Sunday Natural (Berlin) and Donautal Pharma (Bavaria) sell NMN today under the same grey-zone caveats, but most of the NMN actually reaching German doorsteps is mail-order from Chinese makers like EffePharm, often shipped through Hong Kong or Shenzhen. EffePharm is the same company whose Uthever® product just earned the EFSA opinion above.

Regional status table (May 2026):

Region Supplement status Rx / medicine Customs / import
Germany Currently grey zone; EFSA positive safety opinion on Uthever® published 13 May 2026, Commission authorisation pending and product-specific Not approved EU-internal: no issue
Austria Same as Germany (EU rules apply) Not approved EU-internal: no issue
Switzerland Outside EU Novel Food regime; Swissmedic and BLV have their own process Swissmedic regulates medicines Check current BLV status before ordering
USA Lawful as dietary supplement since 29 Sept 2025 FDA amendment Not approved as drug Ships freely within US
China Not approved as food or health food on the mainland (China's NHC rejected NMN as a new food raw material in 2023); cross-border e-commerce (CBEC) is the main route, often shipped from Shanghai or Shenzhen N/A Customs interception possible for EU buyers
Japan Widely sold, openly marketed Not approved as drug Legal export; EU import still bound by EU Novel Food rules

What does this mean if you want to buy it?

Four things are worth knowing if you are shopping for NMN in Germany right now.

1. It is sold online despite the grey zone. NMN turns up on German and EU shops, usually labelled "laboratory chemical" or "research use only" to keep regulators at arm's length. Amazon has yanked NMN from its German marketplace and quietly put it back several times depending on the legal read of the month.

2. A doctor cannot really prescribe it. NMN is not an approved medicine in Germany, which means doctors cannot write the normal pink prescription for it. Some private longevity clinics offer NAD+ infusions (a different substance in a different regulatory bucket) or point patients toward international suppliers, but the legal responsibility for what you put in your body lands squarely on you.

3. Quality and labelling are a coin flip. In a grey-zone market, nobody is closely checking purity or labels, and independent tests by ConsumerLab.com have repeatedly found that the actual NMN inside the capsule can differ sharply from what the bottle promises on the front.

4. EU Health Claims Regulation (plus HWG). For a food supplement, the rule that bans slogans like "NMN rejuvenates cells" or "NMN extends life" is the EU Health Claims Regulation (HCVO, Regulation (EC) No 1924/2006), which only allows health claims that are scientifically proven and on the EU's authorised list. Germany's Heilmittelwerbegesetz (HWG) stacks on top when the claim crosses into medicinal territory (for example "NMN prevents Alzheimer's"), and that is exactly why German sellers keep their product copy deliberately vague.

What about NR, niacinamide, and NAD+?

If you want to explore NAD+ biology while staying inside German rules, you have options, and each one carries a different legal status.

Nicotinamide riboside (NR). Another NAD+ precursor, and the easier of the two to discuss in public. The EU authorised NR as a novel food in 2020 under Commission Implementing Regulation 2020/16, which makes it legally sold in Germany. The human trial record on NR is meaningfully more developed than the one on NMN: Trammell 2016 showed that NR doses up to 1,000 mg raise blood NAD+ pharmacokinetically in healthy adults, and Martens 2018 found that 500 mg twice daily for six weeks lowered systolic blood pressure by about 8 mmHg in adults with stage 1 hypertension. But Dollerup 2018 was negative: 1,000 mg twice daily for 12 weeks did not improve insulin sensitivity in obese men with metabolic syndrome. NAD+ goes up reliably, but whether that buys you years of healthspan is still wide open.

Honest framing on NMN and NR. Both reliably raise NAD+ in blood, neither has a large outcome trial, and most of the rejuvenation evidence comes from rodents or cell lines (some of them cancer cell lines, which is exactly where you do not want to push pro-growth signals). Ferrell 2024 also flagged that high NAD+ turnover can elevate 2PY and 4PY, two metabolites linked in observational data to higher cardiovascular risk. Worth knowing before you commit a year of capsules to either molecule.

Niacin and niacinamide (vitamin B3). The original NAD+ building blocks, long approved and very cheap. Niacin causes the classic warm facial flush, and niacinamide does not, but both raise NAD+ less selectively than NR or NMN.

NAD+ IV drips. Some private clinics and Heilpraktiker offer NAD+ through a drip, and because it counts as a medical service, in Germany it must be delivered by a licensed doctor or a qualified Heilpraktiker under specific conditions. Evidence for lasting effects is thin, and sessions are expensive (usually 200 to 500 euros each).

Lifestyle levers that raise NAD+: exercise, eating fewer calories, and good sleep. All three are well supported by research and sit outside every regulatory question you might have.

What should you check before buying?

If you decide to try NMN despite the legal picture, these are the questions worth putting to a seller or pulling out of the product page before you tap buy.

1. Where is the maker based? EU makers follow EU law, while US and Asian makers do not, so if something goes wrong, recalls, liability, and quality control are much harder to enforce on products shipped from outside the bloc.

2. Is there an independent certificate of analysis (COA)? A serious maker is happy to hand over a COA from an independent lab confirming both purity and actual NMN content, ideally by HPLC or qNMR.

3. How is the product labelled? "Dietary supplement" implies the seller is using the regulated food channel, which is legally shaky for NMN without novel food approval, while "research use only" or "not for human consumption" signals grey-zone selling where the responsibility shifts entirely to you.

4. What does your doctor say? For NAD+ questions, a doctor trained in preventive or functional medicine is usually a better sounding board than a general GP without that background, and these practices are showing up in bigger German cities, mostly on a self-pay basis.

5. Are the promised effects realistic? Honest sources talk about NAD+ levels and mechanisms, so if a product or seller promises concrete longevity, rejuvenation, or disease prevention, that likely breaches the EU Health Claims Regulation (and the HWG if it is framed as medical treatment), and it is also a red flag about how careful the seller actually is.

What to look for on a NMN COA (Certificate of Analysis):

  • Batch / Lot number (matches the bottle you received)
  • Assay method: HPLC or qNMR preferred
  • Purity: ≥98% is the accepted bar
  • Heavy metals panel: Pb, As, Cd, Hg (must be below USP limits)
  • Microbial counts: within food-grade limits
  • Endotoxin: optional for oral; required if injectable/IV
  • Third-party lab name: not the manufacturer's own in-house lab

Linked resources. For the science on NAD+ boosters (NMN and NR side by side), see the NAD+ boosters section of the longevity supplements guide. For dose ranges cited in the literature, see the same longevity supplements guide. Keep in mind that those dose ranges come from US and Asian clinical trials, not from EU-authorised products.

Frequently Asked Questions

Is NMN legal in Germany?

The picture is grey. NMN is classified as a novel food and needs EU authorisation. On 13 May 2026, EFSA published a positive safety opinion on EffePharm's Uthever® NMN (300 mg per day, excluding pregnant and breastfeeding women). European Commission authorisation usually follows 5 to 7 months after a positive EFSA opinion and will be product-specific. Until the EC adopts the authorisation, selling NMN as a supplement is technically out of compliance. Many products are labelled "laboratory chemical" or "research use only," the standard grey-zone workaround. Importing a small amount for personal use is rarely prosecuted, but it is not formally allowed either.

Can my doctor prescribe NMN?

NMN is not an approved medicine in Germany. Doctors cannot prescribe it the usual way. Some private longevity doctors may advise on sources or offer NAD+ infusion alternatives. The legal responsibility for sourcing and taking it sits with you.

What's the difference between NMN and NR?

Both are NAD+ precursors. The biggest practical difference is legal: **NR (nicotinamide riboside) has been EU-authorised as a novel food since 2020** (Regulation 2020/16) and is legally sold as a supplement. NMN is not yet authorised. Their effects on blood NAD+ look similar. Human outcome data is thin for both. NR has more published human trials (Trammell 2016, Martens 2018, Dollerup 2018, the last of which was negative on insulin sensitivity).

Does NMN actually work?

NMN raises blood NAD+ levels. That part is solid. Whether that translates into measurable health or longevity benefits in humans is less clear. Yoshino 2021 showed improved muscle insulin sensitivity in prediabetic women on 250 mg per day. Animal studies show effects on mitochondria (the cell's energy factories) and on metabolism. Large long-term outcome trials with hard endpoints do not exist yet. Ferrell 2024 also flagged that NAD+ turnover can elevate 2PY and 4PY, two metabolites linked in observational data to cardiovascular risk. See our [supplements guide](./longevity-supplements) for the closer scientific look.

Will NMN be approved in the EU soon?

EFSA published a positive safety opinion on EffePharm's Uthever® NMN on 13 May 2026, concluding that 300 mg per day is safe for the general adult population (excluding pregnant and breastfeeding women). European Commission authorisation usually follows 5 to 7 months after a positive EFSA opinion and is product-specific. Generic NMN from other producers stays under Novel Food restrictions until each applicant has its own positive opinion and EC authorisation.

Sources

  1. European Parliament and Council. (2015). Regulation (EU) 2015/2283 on novel foods
  2. European Commission. (2020). Commission Implementing Regulation (EU) 2020/16 authorising nicotinamide riboside chloride as a novel food
  3. Bundesministerium der Justiz. (2024). Heilmittelwerbegesetz (HWG)
  4. US Food and Drug Administration. (2025). FDA Response on the Regulatory Status of NMN as a Dietary Supplement Ingredient
  5. Yoshino M, Yoshino J, Kayser BD, et al.. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Sciencedoi:10.1126/science.abe9985
  6. Igarashi M, Nakagawa-Nagahama Y, Miura M, et al.. (2022). Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. npj Agingdoi:10.1038/s41514-022-00084-z
  7. EFSA NDA Panel. (2026). Safety of β-nicotinamide mononucleotide (NMN) as a novel food. EFSA Journaldoi:10.2903/j.efsa.2026.10007

Questions about longevity rules?

Our local chapters often sit down with doctors, pharmacists, and lawyers to talk through the legal and practical side of longevity products. Join an event near you.

Events near me

Related Guides

The information provided here is for educational purposes only. Longevity Germany does not provide medical advice, diagnosis, or treatment. Always seek the advice of qualified healthcare providers with questions regarding medical conditions.